BD Veritor™ Plus System
Integrated, digitally connected testing that removes any guesswork—by interpreting and providing rapid, clear results for SARS-CoV-2, Flu A+B, SARS-CoV-2 & Flu A+B,* Group A Strep, and RSV—so you can move forward with confidence.
- Overview
- Assays
Invest in simplicity
The BD Veritor™ Plus System is a point-of-care testing solution for SARS-CoV-2, SARS-CoV-2 & Flu A+B,* Flu A+B, Group A Strep, and RSV. It offers:
- The BD Veritor™ Plus Analyzer, a simple, easy-to-use device that delivers unambiguous, rapid and reliable digital results.
- A range of assays to aid clinicians in the diagnosis and management of multiple respiratory infections for symptomatic patients so they can take their next steps with more confidence.
Our Available Assays
Once you have bought the BD Veritor™ Plus Analyzer, you can then order various compatible assays to deliver reliable respiratory infection testing.
How it works
The BD Veritor™ Plus System provides an easy sample-collection process that can be incorporated across a variety of clinical settings.
Trust BD for the Digital Difference
Integrating workflows for reliable results you can act on.
Digital Clarity. Unambiguous positive/negative display which may help to reduce result interpretation errors and streamline diagnosis.
Rapid results. Delivers digitally read results in 15 minutes or less,** supporting timely clinical decisions.
Easy to use. No monthly calibration required, operated with single-button functionality.
Cost-effective. No service contracts, maintenance or calibration needed for device lifetime.
Discover how easy sample collection can simplify testing workflows for reliable results you can act on.
In acute care settings—where health complexities, rapid decision-making, and workflow systems converge—it becomes easy to appreciate the effortlessness with which the BD Veritor™ Plus System accommodates changes in workflow and capacity.
Point-of-care rapid diagnostic testing has become increasingly essential, and the BD Veritor™ Plus System can make a big difference. In-house respiratory tract infection testing with reliable, rapid results means staff is more prepared for rapid triage; able to detect and diagnose infections and even treat a patient in the same visit.
As a community organization, you have many priorities, but we know you have people to protect. You require flexibility, simplicity and reliability, so that those you serve and those who work for you can continue to enjoy life. With the BD Veritor™ Plus System, you can identify certain respiratory infections and then take steps to limit the spread of these respiratory infections throughout your organization and the community.
Why connectivity matters
Connectivity helps results move seamlessly from testing to documentation, so care teams can focus on patients, not paperwork.
- Reduces transcription and documentation errors
- Saves staff time and administrative effort
- Enables real time access to results
Professional Care Testing
Point-of-care testing with SARS-CoV-2, SARS-CoV-2 & Flu A+B,* Flu A+B, RSV and Group A Strep assays, providing rapid diagnostic testing in a convenient, portable instrument.
A 3-in-1 antigen assay for COVID-19, Flu A and Flu B.*
Reliable multiplex results in 15 minutes.1
BD Veritor™ Plus System streamlines clinical and patient workflows by detecting three major respiratory illnesses in one test, reducing the need for multiple sample collections. With multiple testing modes and streamlined workflows, the analyzer empowers convenience and efficiency.
Simplify Flu A+B testing
Streamline your point-of-care flu testing with the portable BD Veritor™ Plus System, which features intuitive operation and timely, reliable results in 10 minutes.1
The BD Veritor™ Plus System offers simple operation, efficient workflows, and reliable, traceable results, which may help improve the patient experience.
Simple RSV testing for those at highest risk.
The portable, easy-to-use BD Veritor™ Plus System for Rapid Detection of RSV provides reliable results in 10 minutes.1
When your pediatric patients** need fast, reliable RSV testing, turn to the BD Veritor™ Plus System. Offering reliable results at point of care in a simple-to-operate, handheld instrument.
CLIA-waived testing for Group A Strep
Achieve accurate Group A Strep results in 5 minutes with the portable, easy-to-use BD Veritor™ Plus System.1
For fast, clear and reliable COVID-19 results, when you need them the most.
Discover the portable, easy-to-use BD Veritor™ Plus System. It provides reliable results in just 15 minutes.1
When your patients need reliable, rapid COVID-19 testing, turn to the BD Veritor™ Plus System. It offers dependable results at the point of care in a simple-to-operate portable instrument.
Get more answers with every sample
Provides results traceability. Captures or downloads the lot number, patient/specimen ID, operator ID, and test records using the BD Veritor™ InfoWifi module (optional add-on feature).
Simplifies the testing process. May reduce manual test processing errors with easy operations and single-button functionality.
Achieves reliable, rapid results. Displays easy-to-read digital results for COVID-19 in 15 minutes1, Flu A+B in 15 minutes1, RSV in 10 minutes1 and Group A Strep in 5 minutes1. Provides clear, objective results by correcting for nonspecific binding and detecting faint lines not recognized by the unaided eye.1
Delivers workflow efficiency. Adapts easily to your workflow by offering two operational modes: Walk away: This allows staff to perform other duties while the sample incubates. Analyze now: Allowing for specimens to be processed in batches.** The Analyzer then performs the analysis and displays the test result.
Contact your Distributor
to place your order
Contact your distributor or call our sales department to purchase.
Not sure which distributor to order from? We can help!
| Distributor | Phone |
|---|---|
| AmerisourceBergen | (610) 727-7000 |
| Cardinal Health Medical Distribution | (800) 964-5227 |
| Cardinal Pharmaceutical | (800) 926-3161 |
| Concordance Healthcare Solutions | (800) 447-0225 |
| CLIA-Waived | (858) 481-5031 |
| Fisher | (800) 640-0640 |
| Henry Schein | (800) 772-4346 |
| McKesson | (800) 654-7240 |
| McKesson Drug | (866) 329-0113 |
| Medline | (800) 633-5463 |
| NDC | (615) 366-3230 |
| TwinMed | (877) 894-6633 |
BD Diagnostic Solutions is Now Waters Advanced Diagnostics
BD Diagnostic Solutions and Biosciences have combined with Waters Corporation to create a life sciences and diagnostics leader driven by innovation and a relentless commitment to our customers.
As we begin our new journey as part of Waters, there will be no immediate changes in how we serve you. The way you order your products and services and how you process payment for them will not change. Your points of contact for sales, customer service, technical service and support or clinical services will remain the same.
Contact a Sales Representative to get your organization’s
diagnostic testing program started today
RSV=respiratory syncytial virus; SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
*In the USA, the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B has not been FDA cleared or approved but has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high, or waived complexity tests. The product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens; and, in the USA, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID 19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
**Result processing times for each BD Veritor™ assay are 15 minutes for the SARS-CoV-2 and SARS-CoV-2 & Flu A+B, 10 minutes for Flu A+B and RSV assays, and 5 minutes for the Group A Strep assay.
